drugset / Trial / NCT01392014

Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases

NCT01392014

Phase 4 Completed 374 enrolled Indonesia University
RandomizedParallel-groupOpen-labelPrevention

Summary

Artemisinin-based combination therapy (ACT) has been known to be controversial for stopping malaria transmission.The addition of primaquine (PQ) - the only drug commercially available that kills mature transmission stage - to such treatments might be necessary to eliminate this stage. A study is conducted to evaluate the efficacy of dihydroartemisinin-piperaquine (DHP) regimens with or without PQ on the sexual and asexual stages of P. falciparum in Sumatra, Indonesia.

Timeline

Start
2008-12
Primary completion
2010-03
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator ARTENIMOL Small molecule 40 mg
Comparator ARTENIMOL Small molecule 60 mg
Comparator ARTENIMOL Small molecule 80 mg
Comparator ARTENIMOL Small molecule 120 mg
Comparator Primaquine Small molecule 0.75 mg/kg
Comparator piperaquine Small molecule 320 mg
Comparator piperaquine Small molecule 480 mg
Comparator piperaquine Small molecule 640 mg
Comparator piperaquine Small molecule 960 mg